Ensidipine Indian version

Ensidipine (enasidenib) is an anti-tumor drug used to treat relapsed or refractory AML with IDH2 mutations. Ensidipine has a significant effect in treating the disease.

There is no officially marketed version of Ensidipine in India. If you buy the Indian version, you are most likely buying an informal product, and the quality and efficacy of the drug are not guaranteed. Currently, there are officially launched versions in Bangladesh and Laos. The retail price of Ziska Pharmaceuticals in Bangladesh is about 50mg60 capsules4 about 1,000 yuan. The retail price of Everest Pharmaceuticals in Bangladesh is 50 mg30tablets5about one thousand yuan, Laos Lucius Pharmaceutical50mg30pills2about one thousand yuan. Patients can choose drug versions based on their financial situation.

Ensidipine dosage Take by mouth once daily at approximately the same time each day. Swallow the tablets with water, without chewing, crushing, or splitting them. If you vomit, miss a dose, or do not take a dose at the usual time, take the dose as soon as possible that day and resume your normal dosing schedule the next day. Do not take 2 doses to make up for the missed dose. Monitor CBC and blood chemistry at least every 2 weeks for at least the first 3 months of treatment. Monitor for signs and symptoms of differentiation syndrome(eg, fever, dyspnea, acute respiratory distress, pulmonary infiltrates, pleural or pericardial effusion, rapid weight gain, peripheral edema, lymphadenopathy, bone pain, and hepatic, renal, or multiorgan dysfunction). If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.